» Authors » Randy Vince Jr

Randy Vince Jr

Explore the profile of Randy Vince Jr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dee E, Todd R, Ng K, Aidoo-Micah G, Amen T, Moon Z, et al.
Nat Rev Urol . 2024 Oct; PMID: 39424981
In the USA, Black men are approximately twice as likely to be diagnosed with and to die of prostate cancer than white men. In the UK, despite Black men having...
2.
Abusamra S, Solorzano M, Quarles J, Luke M, Patel M, Vince Jr R, et al.
Urol Pract . 2024 Oct; 12(1):63-72. PMID: 39383006
Introduction: There is increasing awareness that patients with prostate cancer frequently harbor germline variants that may carry important implications for them and their family members. Given the variable clinical guidelines,...
3.
Zaorsky N, Proudfoot J, Jia A, Zuhour R, Vince Jr R, Liu Y, et al.
JNCI Cancer Spectr . 2023 Aug; 7(5). PMID: 37525535
Background: Management of localized or recurrent prostate cancer since the 1990s has been based on risk stratification using clinicopathological variables, including Gleason score, T stage (based on digital rectal exam),...
4.
Arenas-Gallo C, Owiredu J, Weinstein I, Lewicki P, Basourakos S, Vince Jr R, et al.
Nat Rev Urol . 2022 Aug; 19(9):547-561. PMID: 35945369
In the past 20 years, new insights into the genomic pathogenesis of prostate cancer have been provided. Large-scale integrative genomics approaches enabled researchers to characterize the genetic and epigenetic landscape...
5.
Chowdhury-Paulino I, Ericsson C, Vince Jr R, Spratt D, George D, Mucci L
Prostate Cancer Prostatic Dis . 2021 Sep; 25(3):397-402. PMID: 34475523
Prostate cancer has the widest racial disparities of any cancer, and these disparities appear at every stage of the cancer continuum. This review focuses on the disparities in prostate cancer...
6.
Vince Jr R
JAMA Oncol . 2021 Jul; 7(10):1474-1475. PMID: 34292296
No abstract available.
7.
Vince Jr R, Spratt D
Prostate Cancer Prostatic Dis . 2021 Jul; 24(4):946-947. PMID: 34253848
No abstract available.
8.
Cani A, Hu K, Liu C, Siddiqui J, Zheng Y, Han S, et al.
Eur Urol Oncol . 2021 Apr; 5(4):430-439. PMID: 33812851
Background: Despite biomarker development advances, early detection of aggressive prostate cancer (PCa) remains challenging. We previously developed a clinical-grade urine test (Michigan Prostate Score [MiPS]) for individualized aggressive PCa risk...
9.
Jairath N, Dal Pra A, Vince Jr R, Dess R, Jackson W, Tosoian J, et al.
Eur Urol . 2020 Dec; 79(3):374-383. PMID: 33293078
Context: Molecular biomarkers aim to address the established limitations of clinicopathologic factors to accurately risk stratify patients with prostate cancer (PCa). Questions remain as to whether sufficient evidence supports adoption...